Search

everythinglearnresearchcommunity

for

Search:↓

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

An elderly Chinese man lost all his hair after taking a new heart medication.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

The drug combination was safe and showed promise in treating advanced tumors.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Low-dose rapamycin microdepots can help regrow hair by activating certain cell processes.

Rituximab can cause skin issues, but baricitinib may help improve them.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Silymarin with hair follicle transplantation might help treat stubborn vitiligo, but more research is needed.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Belimumab effectively controls SLE disease activity and reduces steroid use.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.